Literature DB >> 20160578

More indirect evidence of potential neuroprotective benefits of angiotensin receptor blockers.

Craig Anderson.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20160578     DOI： 10.1097/HJH.0b013e3283371355

Source DB:  PubMed          Journal:  J Hypertens        ISSN： 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  8 in total

Review 1.  Angiotensin II AT(1) receptor blockers ameliorate inflammatory stress: a beneficial effect for the treatment of brain disorders.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2011-09-22       Impact factor: 5.046

Review 2.  Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.

Authors:  Juan M Saavedra; Enrique Sánchez-Lemus; Julius Benicky
Journal:  Psychoneuroendocrinology       Date:  2010-10-29       Impact factor: 4.905

Review 3.  Autonomic and inflammatory consequences of posttraumatic stress disorder and the link to cardiovascular disease.

Authors:  Chevelle Brudey; Jeanie Park; Jan Wiaderkiewicz; Ihori Kobayashi; Thomas A Mellman; Paul J Marvar
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-06-10       Impact factor: 3.619

Review 4.  Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.

Authors:  Juan M Saavedra
Journal:  Clin Sci (Lond)       Date:  2012-11       Impact factor: 6.124

5.  The renin-angiotensin pathway in posttraumatic stress disorder: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are associated with fewer traumatic stress symptoms.

Authors:  Nayla M Khoury; Paul J Marvar; Charles F Gillespie; Aliza Wingo; Ann Schwartz; Bekh Bradley; Michael Kramer; Kerry J Ressler
Journal:  J Clin Psychiatry       Date:  2012-05-01       Impact factor: 4.384

6.  Telmisartan ameliorates glutamate-induced neurotoxicity: roles of AT(1) receptor blockade and PPARγ activation.

Authors:  Juan Wang; Tao Pang; Roman Hafko; Julius Benicky; Enrique Sanchez-Lemus; Juan M Saavedra
Journal:  Neuropharmacology       Date:  2013-12-04       Impact factor: 5.250

7.  Angiotensin II AT1 receptor blockade ameliorates brain inflammation.

Authors:  Julius Benicky; Enrique Sánchez-Lemus; Masaru Honda; Tao Pang; Martina Orecna; Juan Wang; Yan Leng; De-Maw Chuang; Juan M Saavedra
Journal:  Neuropsychopharmacology       Date:  2010-12-08       Impact factor: 7.853

8.  An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's disease.

Authors:  Abdel G Elkahloun; Roman Hafko; Juan M Saavedra
Journal:  Alzheimers Res Ther       Date:  2016-01-28       Impact factor: 6.982
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.